Tracking hunger, cravings, and meals over time helps you understand the change and make sure you are still fueling your body well
Helps reduce dullness caused by pollution and stress 2
GLP-1 medications typically cause nausea (especially during dose increases), constipation, and mild gastrointestinal changes, which often improve as your body adapts
Tirzepatide activates GLP-1 and GIP receptors and slows gastric emptying, so there is already less fluid moving through comfortably
Both semaglutide (Wegovy) and tirzepatide (Zepbound) are recommended by NICE within specific clinical criteria, which typically include a BMI of 35 kg/m or above alongside at least one weight-related comorbidity, or a BMI of 30 kg/m or above in certain higher-risk groups, and access is generally through specialist NHS weight management services
Many parents find comfort in connecting with other families during their hospital stay